For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $2.07 in the prior trading day, Adc Therapeutics SA (NYSE: ADCT) closed at $1.92, down -7.25%. In other words, the price has decreased by -$7.25 from its previous closing price. On the day, 0.74 million shares were traded. ADCT stock price reached its highest trading level at $2.02 during the session, while it also had its lowest trading level at $1.8.
Ratios:
Our goal is to gain a better understanding of ADCT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.68 and its Current Ratio is at 4.92.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Overweight rating and assigned the stock a target price of $6.
On March 28, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.Guggenheim initiated its Buy rating on March 28, 2024, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’24 when Redmile Group, LLC bought 400,000 shares for $2.81 per share. The transaction valued at 1,124,000 led to the insider holds 15,669,217 shares of the business.
Redmile Group, LLC bought 400,000 shares of ADCT for $1,124,000 on Jul 01 ’24. The 10% Owner now owns 12,995,040 shares after completing the transaction at $2.81 per share. On Jun 17 ’24, another insider, Azelby Robert, who serves as the Director of the company, sold 6,995 shares for $2.89 each. As a result, the insider received 20,216 and left with 53,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADCT now has a Market Capitalization of 200146560 and an Enterprise Value of 365768064. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.63. Its current Enterprise Value per Revenue stands at 5.172 whereas that against EBITDA is -2.672.
Stock Price History:
Over the past 52 weeks, ADCT has reached a high of $6.04, while it has fallen to a 52-week low of $0.94. The 50-Day Moving Average of the stock is -30.74%, while the 200-Day Moving Average is calculated to be -45.17%.
Shares Statistics:
The stock has traded on average 388.37K shares per day over the past 3-months and 431230 shares per day over the last 10 days, according to various share statistics. A total of 96.69M shares are outstanding, with a floating share count of 77.83M. Insiders hold about 19.50% of the company’s shares, while institutions hold 55.42% stake in the company. Shares short for ADCT as of 1731628800 were 3164460 with a Short Ratio of 8.15, compared to 1728950400 on 3508209. Therefore, it implies a Short% of Shares Outstanding of 3164460 and a Short% of Float of 4.68.
